Cefuroxime: Cefuroxime is a broad-spectrum antibiotic effective against a wide range of bacterial infections. It works by interfering with the synthesis of bacterial cell walls, leading to the disruption of bacterial growth and eventual eradication. Cefuroxime is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain types of bacterial meningitis. Its potency and broad spectrum of activity make it a versatile choice for combating bacterial infections.

Clavulanic Acid: Clavulanic Acid enhances the effectiveness of antibiotics, such as Cefuroxime, by inhibiting beta-lactamase enzymes produced by some bacteria. Beta-lactamases are responsible for breaking down antibiotics, rendering them ineffective against bacterial infections. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing the degradation of Cefuroxime by these enzymes and extending its antibacterial activity. This combination enhances the spectrum of activity and ensures the efficacy of Cefuroxime against a wider range of bacteria, including those that may be resistant to antibiotics.

Ciffor-CV Tablets are indicated for the treatment of various bacterial infections caused by susceptible organisms. These infections may include respiratory tract infections, such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and certain types of bacterial meningitis. The synergistic action of Cefuroxime and Clavulanic Acid makes Ciffor-CV Tablets an effective choice for combating moderate to severe bacterial infections.